Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
ESMO Congress 2025
ACS Clinical Congress 2025
2025 ASCO Quality Care Symposium
2025 ASTRO Annual Meeting
2025 Debates and Didactics in Hematology and Oncology
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
NCCN 2018 Annual Conference,NCCN 2018 Annual Conference
«
1
»
Advertisement
Advertisement
Oct
21
Today In Oncology
Metastatic ER-Positive HER2-Negative Breast Cancer Novel Treatment Combination Improves Progression-Free Survival
ADC Improves Outcomes for Patients With Advanced TNBC Ineligible for Immunotherapy
RCC: Lenvatinib/Everolimus Extends PFS After PD-1 Inhibition
Belzutifan Achieves Durable Responses Without Surgery in Advanced Pheochromocytoma Paraganglioma
VT3989 Demonstrates Antitumor Activity and Tolerability in Refractory Mesothelioma
View More
Advertisement
